Amryt Pharma plc Retained Earnings 2011-2026 | AMYT

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Amryt Pharma plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-236 M	84 M	-69.6 M	-42.1 M	-9.46 M	-44.8 M	-5.05 M	-2.49 M	-3.11 M	-3.72 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
84 M	-236 M	-33.2 M

Quarterly Retained Earnings Amryt Pharma plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-233 M	-	-	-	-236 M	-	-	-	-131 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-131 M	-236 M	-200 M

Retained Earnings of other stocks in the Biotechnology industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
argenx SE ARGX	-861 M	$ 831.0	-0.3 %	$ 25 B	Niderland
MorphoSys AG MOR	-158 M	-	2.43 %	$ 254 M	Germany
Amarin Corporation plc AMRN	-1.59 B	$ 14.75	-0.74 %	$ 6.01 B	Irlanda
Acer Therapeutics ACER	-141 M	-	2.71 %	$ 14 M	USA
Acasti Pharma ACST	-221 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	-8.33 B	-	-	$ 866 M	China
Adverum Biotechnologies ADVM	-1.07 B	-	-	$ 86.2 M	USA
Anavex Life Sciences Corp. AVXL	-382 M	$ 4.12	5.07 %	$ 351 M	USA
Applied Genetic Technologies Corporation AGTC	-308 M	-	-	$ 26.5 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.24 B	-	-	$ 40.3 B	USA
Adagene ADAG	-311 M	$ 3.17	11.23 %	$ 178 M	China
Biophytis SA BPTS	-17.1 M	-	-13.47 %	$ 169 M	France
Akouos AKUS	-168 M	-	0.23 %	$ 488 M	USA
Aptorum Group Limited APM	-72.4 M	$ 0.77	-10.2 %	$ 4.2 M	China
AlloVir ALVR	-715 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	-122 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-108 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	-243 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	-182 M	$ 3.48	-0.83 %	$ 8.37 B	Australia
Applied Molecular Transport AMTI	-366 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	-83.7 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	-1.19 B	-	-24.86 %	$ 820 K	USA
Aptose Biosciences APTO	-541 M	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	-826 M	-	-	$ 3.67 B	USA
Athira Pharma ATHA	-406 M	-	-	$ 269 M	USA
Aeglea BioTherapeutics AGLE	-972 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	-301 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	69.4 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	-246 M	-	3.16 %	$ 1.9 M	USA
Ascendis Pharma A/S ASND	-611 M	$ 215.19	-1.33 %	$ 5 B	Danmark
Aptinyx APTX	-353 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-616 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	-2.12 B	-	-6.81 %	$ 3.04 B	USA
Biogen BIIB	20.6 B	$ 197.11	0.82 %	$ 28.9 B	USA
Aridis Pharmaceuticals ARDS	-196 M	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	-335 M	-	5.93 %	$ 314 M	Canada
Brickell Biotech BBI	-172 M	-	-5.38 %	$ 6.06 M	USA
AgeX Therapeutics AGE	-131 M	-	-10.17 %	$ 12.2 K	USA
Bristol-Myers Squibb Company BMY	16.9 B	$ 60.64	1.33 %	$ 123 B	USA
Athersys ATHX	-583 M	-	3.77 %	$ 22.4 M	USA
BioNTech SE BNTX	-410 M	$ 106.73	0.92 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	-103 M	-	-52.27 %	$ 4.45 M	USA
BeiGene, Ltd. BGNE	-8.61 B	-	0.49 %	$ 251 B	Cayman-islands
Autolus Therapeutics plc AUTL	-1.1 B	$ 1.4	1.59 %	$ 357 M	Britain
Amneal Pharmaceuticals AMRX	-607 M	$ 14.93	2.05 %	$ 4.61 B	USA
AIkido Pharma AIKI	-223 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	-477 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	-1.06 B	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	-224 M	-	-	$ 2.17 B	USA